UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 6 Issue 3
March-2019
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR1903769


Registration ID:
193728

Page Number

520-536

Share This Article


Jetir RMS

Title

FORMULATION AND EVALUATION OF ROPINIROLE HYDROCHLORIDE BUCCAL TABLETS

Abstract

Buccal route offers excellent opportunities and potential advantages for systemic drug delivery as compared to pre-oral administration. The objective of this study was to prepare Ropinirole hydrochloride buccal tablets. The Ropinirole Hydrochloride is a non-ergoline dopamine agonist with high relative specificity and full intrinsic activity at the D2 and D3 dopamine receptor subtypes. This action in humans correlates with treatment for Parkinson’s disease due to stimulation of postsynaptic dopamine D2-type receptors. Ropinirole hydrochloride after oral administration shows a lesser bio availability up to 55% with a biological half-life of 4 to 6hours. To increase the bioavailability has drug as good buccal absorption. Ropinirole hydrochloride buccal tablets were prepared by direct compression method using guar gum and badam gum as natural polymers, carbopol 934P and HPMC K15M as mucoadhesive polymers. Tablets were evaluated for physical properties, drug content, swelling index, mucoadhesion, and in-vitro dissolution studies. An optimized formulation F6 was found to be having good mucoadhesive strength 345.74mg, 352.84mg. ; mucoadhesive residence time was found to be more than 6 hours and cumulative percentage drug release 98.29%, 99.87% within 6hours.Release kinetic model studies indicated that optimized batch followed diffusive mechanism with zero order release kinetics.

Key Words

Ropinirole hydrochloride, mucoadhesion, direct compression method, buffer, drug release studies

Cite This Article

"FORMULATION AND EVALUATION OF ROPINIROLE HYDROCHLORIDE BUCCAL TABLETS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.6, Issue 3, page no.520-536, March-2019, Available :http://www.jetir.org/papers/JETIR1903769.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"FORMULATION AND EVALUATION OF ROPINIROLE HYDROCHLORIDE BUCCAL TABLETS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.6, Issue 3, page no. pp520-536, March-2019, Available at : http://www.jetir.org/papers/JETIR1903769.pdf

Publication Details

Published Paper ID: JETIR1903769
Registration ID: 193728
Published In: Volume 6 | Issue 3 | Year March-2019
DOI (Digital Object Identifier):
Page No: 520-536
Country: HYDERABAD, TELANGANA, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0003045

Print This Page

Current Call For Paper

Jetir RMS